| 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and … F Cosentino, PJ Grant, V Aboyans, CJ Bailey, A Ceriello, V Delgado, ... European heart journal 41 (2), 255-323, 2020 | 4335 | 2020 |
| European guidelines on cardiovascular disease prevention in clinical practice; third joint task force of European and other societies on cardiovascular disease prevention in … G De Backer, E Ambrosioni, K Borch-Johnsen, C Brotons, R Cifkova, ... European Journal of Preventive Cardiology 10 (4), S1-S10, 2003 | 3504 | 2003 |
| Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. World Health Organization, International Diabetes Federation World Health Organization, 2006 | 3316 | 2006 |
| Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial PD Home, SJ Pocock, H Beck-Nielsen, PS Curtis, R Gomis, M Hanefeld, ... The Lancet 373 (9681), 2125-2135, 2009 | 1734 | 2009 |
| Rosiglitazone evaluated for cardiovascular outcomes—an interim analysis PD Home, SJ Pocock, H Beck-Nielsen, R Gomis, M Hanefeld, NP Jones, ... New England Journal of Medicine 357 (1), 28-38, 2007 | 1048 | 2007 |
| A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with … K Hermansen, M Davies, T Derezinski, G Martinez Ravn, P Clauson, ... Diabetes care 29 (6), 1269-1274, 2006 | 910 | 2006 |
| A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with … J Rosenstock, M Davies, PD Home, J Larsen, C Koenen, G Schernthaner Diabetologia 51, 408-416, 2008 | 711 | 2008 |
| A desktop guide to Type 1 (insulin‐dependent) diabetes mellitus European Diabetes Policy group Diabetic Medicine 16 (3), 253-266, 1999 | 685 | 1999 |
| Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3). JBS3 Board Heart 100 (suppl 2), 1-67, 2014 | 659 | 2014 |
| Global guideline for type 2 diabetes P Aschner, H Beck Nielsen, P Bennet, A Boulton, R Colagiuri, S Colagiuri, ... Diabetes Research and Clinical Practice 104, 1-52, 2014 | 618 | 2014 |
| Blood glucose control and the evolution of diabetic retinopathy and albuminuria: a preliminary multicenter trial. Kroc Collaborative Study Group N Engl J Med 311, 365-372, 1984 | 613 | 1984 |
| Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum SC Smith Jr, R Jackson, TA Pearson, V Fuster, S Yusuf, O Faergeman, ... Circulation 109 (25), 3112-3121, 2004 | 534 | 2004 |
| The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease L Sibal, S C Agarwal, P D Home, R H Boger Current cardiology reviews 6 (2), 82-90, 2010 | 531 | 2010 |
| New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using basal and mealtime insulin: glucose control and hypoglycemia in a 6-month … MC Riddle, GB Bolli, M Ziemen, I Muehlen-Bartmer, F Bizet, PD Home Diabetes care 37 (10), 2755-2762, 2014 | 430 | 2014 |
| New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin‐naive people with type 2 diabetes on oral glucose‐lowering drugs: a randomized controlled trial (EDITION 3) GB Bolli, MC Riddle, RM Bergenstal, M Ziemen, K Sestakauskas, ... Diabetes, Obesity and Metabolism 17 (4), 386-394, 2015 | 401 | 2015 |
| Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L) MC Riddle, R Aronson, P Home, M Marre, E Niemoeller, P Miossec, ... Diabetes care 36 (9), 2489-2496, 2013 | 357 | 2013 |
| Guidelines for the treatment and management of new‐onset diabetes after transplantation1 A Wilkinson, J Davidson, F Dotta, PD Home, P Keown, B Kiberd, ... Clinical transplantation 19 (3), 291-298, 2005 | 357 | 2005 |
| Insulin aspart vs. human insulin in the management of long‐term blood glucose control in type 1 diabetes mellitus: a randomized controlled trial PD Home, A Lindholm, A Riis, European Insulin Aspart Study Group Diabetic medicine 17 (11), 762-770, 2000 | 338 | 2000 |
| Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in type 1 and type 2 diabetic patients BO Boehm, PD Home, C Behrend, NM Kamp, A Lindholm Diabetic Medicine 19 (5), 393-399, 2002 | 336 | 2002 |
| Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group. PD Home, A Lindholm, B Hylleberg, P Round Diabetes Care 21 (11), 1904-1909, 1998 | 312 | 1998 |
John McMurrayUniversity of Glasgow.Підтверджена електронна адреса в glasgow.ac.uk
